Drug evolution concept in drug design : 2. Chimera method

From National Research Council Canada

DOIResolve DOI: https://doi.org/10.2174/157340606776056214
AuthorSearch for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 ; Search for: 1 
Name affiliation
  1. National Research Council Canada. NRC Biotechnology Research Institute
FormatText
TypeArticle
ISSN1573-4064
Volume2
Issue2
Pages175189; # of pages: 15
SubjectChimera method; drug design; drug library; pha; scaffold; para-aminobenzoic acid; building blocks; drug evolution; 4-aminobenzoic acid; animals; binding sites; chemistry, pharmaceutical; chimera; combinatorial chemistry techniques; drug design; drug evaluation, preclinical; salicylic acid; structure-activity relationship
Abstract
Publication date
Terms of use
NoteEnglish16787366
LanguageEnglish
Identifier20852708
NRC number47487
NPARC number3539192
Export citationExport as RIS
Report a correctionReport a correction
Record identifiera3cdce56-7c86-4938-9fb3-a47d028f93a0
Record created2009-03-01
Record modified2019-02-18
Date modified: